Coherus BioSciences, Inc. (CHRS) NASDAQ

0.81

+0.0053(+0.66%)

Updated at June 06 11:33AM

Currency In USD

Valuation

Market Cap158.08M
Enterprise Value302M
P/E Ratio-0.71
PEG Ratio0
Price/Sales Ratio0.47
Price/Book Ratio-0.51
Enterprise/Revenue1.23
Enterprise/EBITDA-2.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.66
Operating Margin-0.58

Management Effectiveness

Return On Assets-0.35
Return On Equity1.07

Income Statement

Revenue266.96M
Revenue/Share1.7
Gross Profit149.41M
EBITDA60.94M
Net Income28.51M
Diluted EPS0.25

Balance Sheet

Total Cash82.41M
Total Cash/Share0.71
Total Debt231.42M
Total Debt/Equity-1.26
Current Ratio1.22
Book Value Per Share-1.58

Price History

52-Week Change-53.7
52-Week High2.43
52-Week Low0.66
Moving Average 50 Days0.89
Moving Average 200 Days1.09

Statistics

Average Volume1.81M
Shares Outstanding115.93M
% Held by Institutions53.58

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A